MedTrace Logo

WOLF - Feasibility Neurothrombectomy Study in Acute Ischemic Stroke Patients

NCT03781622 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-01-23

No results posted yet for this study

Summary

This study is being conducted as a feasibility clinical investigation to collect safety and technical performance data of the WOLF Thrombectomy Device for the removal of thrombus in the neurovasculature.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

WOLF Thrombectomy Device

Mechanical thrombectomy for the neurovasculature

Sponsors & Collaborators

  • 880 Medical, LLC

    lead INDUSTRY

Principal Investigators

  • Brian van Adel, MD · Hamilton General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2019-12-30
Completion
2019-12-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03781622 on ClinicalTrials.gov